Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Thomas P Lodise & Sanjay Sethi. (2021) Response to the Letter to the Editor Regarding “Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies” [Response to Letter]. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1227-1229.
Read now
Read now
Thomas P Lodise, Jingyi Li, Hitesh N Gandhi, Gerald O’Brien & Sanjay Sethi. (2020) Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2889-2900.
Read now
Read now
Paolo Solidoro, Filippo Patrucco & Diego Bagnasco. (2019) Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review. Expert Review of Respiratory Medicine 13:11, pages 1087-1094.
Read now
Read now
Donald P Tashkin & Charlie Strange. (2018) Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2587-2601.
Read now
Read now
Kylie BR Belchamber, Catherine MR Thomas, Amy E Dunne, Peter J Barnes & Louise E Donnelly. (2018) Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2883-2897.
Read now
Read now
Chih-Cheng Lai, Ya-Hui Wang, Cheng-Yi Wang, Hao-Chien Wang, Chong-Jen Yu & Likwang Chen. (2018) Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 867-874.
Read now
Read now
Ying-Huang Tsai, Tsung-Ming Yang, Chieh-Mo Lin, Shu-yi Huang & Yu-Wen Wen. (2017) Trends in health care resource utilization and pharmacological management of COPD in Taiwan from 2004 to 2010. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2787-2793.
Read now
Read now
Articles from other publishers (9)
Ralph Brattsand & Olof Selroos. (2022) May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?. Pulmonary Pharmacology & Therapeutics 77, pages 102167.
Crossref
Crossref
Marc Miravitlles, Ariadna Auladell-Rispau, Mònica Monteagudo, Juan Carlos Vázquez-Niebla, Jibril Mohammed, Alexa Nuñez & Gerard Urrútia. (2021) Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD. European Respiratory Review 30:160, pages 210075.
Crossref
Crossref
Melissa H. Roberts & Gary T. Ferguson. (2020) Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions. PharmacoEconomics - Open 5:1, pages 3-11.
Crossref
Crossref
Cheng-Yi Wang, Ya-Hui Wang & Chih-Cheng Lai. (2020) Different ICSs and the Risk of Pneumonia. Chest 157:5, pages 1395.
Crossref
Crossref
Ting-Yu Chang, Jung-Yien Chien, Chung-Hsuen Wu, Yaa-Hui Dong & Fang-Ju Lin. (2020) Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β2-Agonist Combinations in Patients With COPD. Chest 157:5, pages 1117-1129.
Crossref
Crossref
Emil Ekbom, Jennifer Quint, Linus Schöler, Andrei Malinovschi, Karl Franklin, Mathias Holm, Kjell Torén, Eva Lindberg, Deborah Jarvis & Christer Janson. (2019) Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia. BMC Pulmonary Medicine 19:1.
Crossref
Crossref
Christer Janson, Gunnar Johansson, Björn Ställberg, Karin Lisspers, Petter Olsson, Dorothy L. Keininger, Milica Uhde, Florian S. Gutzwiller, Leif Jörgensen & Kjell Larsson. (2018) Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study. Respiratory Research 19:1.
Crossref
Crossref
Cheng-Hsin Chen, Chih-Cheng Lai, Ya-Hui Wang, Cheng-Yi Wang, Hao-Chien Wang, Chong-Jen Yu & Likwang Chen. (2018) The Impact of Sepsis on the Outcomes of COPD Patients: A Population-Based Cohort Study. Journal of Clinical Medicine 7:11, pages 393.
Crossref
Crossref
M. van den Berge, M.R. Jonker, A. Miller-Larsson, D.S. Postma & I.H. Heijink. (2018) Effects of fluticasone propionate and budesonide on the expression of immune defense genes in bronchial epithelial cells. Pulmonary Pharmacology & Therapeutics 50, pages 47-56.
Crossref
Crossref